State of Alaska Department of Revenue’s Maravai LifeSciences MRVI Stock Holding History

State of Alaska Department of Revenue’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-391,544	Closed	-$2.56M	–	1604
2023 Q4	$2.56M	Hold	391,544	–	–	0.03%	590
2023 Q3	$3.92M	Hold	391,544	–	–	0.05%	422
2023 Q2	$4.87M	Hold	391,544	–	–	0.06%	375
2023 Q1	$5.49M	Hold	391,544	–	–	0.07%	341
2022 Q4	$5.6M	Buy	+391,544	New	+$6.16M	0.07%	326

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State of Alaska Department of Revenue's MRVI Position: Q1 2024 in Review

State of Alaska Department of Revenue sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 391,544 shares — an estimated $2.56M sold.

State of Alaska Department of Revenue first reported a position in MRVI in Q4 2022 and held it in 5 quarters. The position peaked at $5.6M in Q4 2022. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

State of Alaska Department of Revenue reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
State of Alaska Department of Revenue sold 391,544 Maravai LifeSciences shares in Q1 2024, an estimated $2.56M.
State of Alaska Department of Revenue first reported a position in Maravai LifeSciences in Q4 2022 and held it in 5 quarters.
State of Alaska Department of Revenue's Maravai LifeSciences position peaked at $5.6M in Q4 2022.
210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on State of Alaska Department of Revenue's 13F filing for Q1 2024, filed 19 Apr 2024.